An animal model for progressive multifocal leukoencephalopathy

Journal of Clinical Investigation

Volumn 124, Issue 12, 2014, Pages 5103-5106

  Haley, Sheila A ^a   Atwood, Walter J ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN BASIC PROTEIN;

ANIMAL MODEL; ASTROCYTE; GLIA CELL; HUMAN; INCIDENCE; JC VIRUS; NONHUMAN; NOTE; OLIGODENDROGLIA; PATHOGENESIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; ANIMAL; FEMALE; HISTOCOMPATIBILITY; IMMUNOLOGY; MALE; PHYSIOLOGY; STEM CELL; STEM CELL TRANSPLANTATION; VIRUS REPLICATION;

ANIMALS; ASTROCYTES; FEMALE; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION CHIMERA; VIRUS REPLICATION;

EID: 84915818681     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI79186     Document Type: Note

References (33)

1. Astrom K, Mancall E, Richardson EP Jr. Progressive multifocal leukoencephalopathy. Brain. 1958;81(1):93-127.
2. Richardson EP Jr. Progressive multifocal leukoencephalopathy. N Engl J Med. 1961;265:815-823.
3. Mollenhauer HH. Plastic embedding mixtures for use in electron microscopy. Stain Technol. 1964;39:111-114.
4. Padgett B, ZuRhein G, Walker D, Echroade R, Dessel B. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet. 1971;1(7712):1257-1260.
5. Major EO, Miller AE, Mourrain P, Traub RG, de Widt E, Sever J. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc Natl Acad Sci U S A. 1985;82(4):1257-1261.
6. Mandl C, Walker DL, Frisque RJ. Derivation and characterization of POJ cells, transformed human fetal glial cells that retain their permissivity for JC Virus. J Virol. 1987;61(3):755-763.
7. Aksamit AJ, Major EO, Ghatak NR, Sidhu GS, Parisi JE, Guccion JG. Diagnosis of progressive multifocal leukoencephalopathy by brain biopsy with biotin labelled DNA:DNA in situ hybridization. J Neuropathol Exp Neurol. 1987;46(5):556-566.
8. Houff SA, Katz D, Kufta CV, Major EO. A rapid method for in situ hybridization for viral DNA in brain biopsies from patients with AIDS. AIDS. 1989;3(12):843-845.
9. Houff SA, et al. Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med. 1988;318(5):301-305.
10. Ferenczy MW, et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 2012;25(3):471-506.
11. Berger JR, Khalili K. The pathogenesis of progressive multifocal leukoencephalopathy. Discov Med. 2011;12(67):495-503.
12. Jensen PN, Major EO. A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region. J Neurovirol. 2001;7(4):280-287.
13. Johnson EM, Wortman MJ, Dagdanova AV, Lundberg PS, Daniel DC. Polyomavirus JC in the context of immunosuppression: a series of adaptive, DNA replication-driven recombination events in the development of progressive multifocal leukoencephalopathy. Clin Dev Immunol. 2013;2013:197807.
14. Kondo Y, et al. Human glial chimeric mice reveal astrocytic dependence of JC virus infection. J Clin Invest. 2014;124(12):5323-5336.
15. Holman RC, Torok TJ, Belay ED, Janssen RS, Schonberger LB. Progressive multifocal leukoencephalopathy in the United States, 1979-1994: increased mortality associated with HIV infection. Neuroepidemiology. 1998;17(6):303-309.
16. Holman RC, Janssen RS, Buehler JW, Zelasky MT, Hooper WC. Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data. Neurology. 1991;41(11):1733-1736.
17. Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 1992;5(1):49-73.
18. Van Assche G, et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med. 2005;353(4):362-368.
19. Kleinschmidt-DeMasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med. 2005;353(4):369-374.
20. Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med. 2005;353(4):375-381.
21. Clifford DB. Progressive multifocal leukoencephalopathy therapy [published online ahead of print September 17, 2014]. J Neurovirol. doi:10.1007/s13365-014-0289-8.
22. De Luca A, et al. Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. AIDS. 2008;22(14):1759-1767.
23. Clifford DB, et al. A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes. J Neurovirol. 2013;19(4):351-358.
24. Kerr DA, Chang CF, Gordon J, Bjornsti MA, Khalili K. Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin. Virology. 1993;196(2):612-618.
25. Brickelmaier M, et al. Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother. 2009;53(5):1840-1849.
26. Hou J, Major EO. The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. J Neurovirol. 1998;4(4):451-456.
27. Fonseca-Elphick G, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science. 2004;306(5700):1241-1420.
28. Carney DW, et al. Structural optimization of a retrograde trafficking inhibitor that protects cells from infections by human polyoma- and papillomaviruses. Bioorg Med Chem. 2014;22(17):4836-4847.
29. Nelson CD, et al. A retrograde trafficking inhibitor of ricin and Shiga-like toxins inhibits infection of cells by human and monkey polyomaviruses. MBio. 2013;4(6):e00729-e00713.
30. Reid CE, et al. Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients. J Infect Dis. 2011;204(2):237-244.
31. Gorelik L, et al. Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity. J Infect Dis. 2011;204(1):103-114.
32. Maginnis MS, et al. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding. MBio. 2013;4(3):e00247-e00213.
33. Neu U, et al. Structure-function analysis of the human JC polyomavirus establishes the LSTc pentasaccharide as a functional receptor motif. Cell Host Microbe. 2010;8(4):309-319.